The name of the medicinal product, the dose of the active ingredient and the dosage form shall also be indicated in Braille on the outer package of a medicinal product. The central executive authority in charge of shaping the state policy in the field of healthcare shall define medicinal products, the package of which shall not be labelled in Braille or only the name of a medicinal product shall be indicated in Braille.